Atlas Venture has 23 tracked deals to Goldman Sachs's 27. Stage focus, check size, and sector fit compared side by side.
Atlas Venture is a venture capital based in Cambridge, MA, USA with 23 tracked deals. Goldman Sachs is a accelerator based in Chicago, IL, United States with 27 tracked deals. Goldman Sachs shows 4 more tracked rounds than Atlas Venture in this dataset, which is the clearest signal of deployment pace between the two. Sector focus diverges: Atlas Venture concentrates on Biotech, Digital Health and Fintech and Goldman Sachs on generalist deals. On stage, Atlas Venture is active at Seed and Series A and Goldman Sachs at undisclosed stages. Recent tracked names include AAVantgarde Bio and Affinia Therapeutics for Atlas Venture and Alterome Therapeutics and Amount for Goldman Sachs.
Investors like Atlas Venture · Investors like Goldman Sachs · Atlas Venture co-investors · Full investor directory